Verona Pharma PLC
F:I9SA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
V
|
Verona Pharma PLC
F:I9SA
|
UK |
|
M
|
MaxCyte Inc
NASDAQ:MXCT
|
US |
|
I
|
Imperial Brands PLC
OTC:IMBBF
|
UK |
|
Grupo Aeroportuario del Sureste SAB de CV
OTC:ASRMF
|
MX |
|
Firstcash Holdings Inc
F:FF60
|
US |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is I9SA's stock price target?
Not Available
I9SA does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Verona Pharma PLC?
Projected CAGR
202%
The compound annual growth rate for Revenue over the next 3 years is 202%.